Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Metabolic reprogramming of fibro/adipogenic progenitors facilitates muscle regeneration.

Reggio A, Rosina M, Krahmer N, Palma A, Petrilli LL, Maiolatesi G, Massacci G, Salvatori I, Valle C, Testa S, Gargioli C, Fuoco C, Castagnoli L, Cesareni G, Sacco F.

Life Sci Alliance. 2020 Feb 4;3(3). pii: e202000646. doi: 10.26508/lsa.202000660. Print 2020 Mar.

2.

Myo-REG: A Portal for Signaling Interactions in Muscle Regeneration.

Palma A, Cerquone Perpetuini A, Ferrentino F, Fuoco C, Gargioli C, Giuliani G, Iannuccelli M, Licata L, Micarelli E, Paoluzi S, Perfetto L, Petrilli LL, Reggio A, Rosina M, Sacco F, Vumbaca S, Zuccotti A, Castagnoli L, Cesareni G.

Front Physiol. 2019 Sep 27;10:1216. doi: 10.3389/fphys.2019.01216. eCollection 2019.

3.

Fibro-adipogenic progenitors of dystrophic mice are insensitive to NOTCH regulation of adipogenesis.

Marinkovic M, Fuoco C, Sacco F, Cerquone Perpetuini A, Giuliani G, Micarelli E, Pavlidou T, Petrilli LL, Reggio A, Riccio F, Spada F, Vumbaca S, Zuccotti A, Castagnoli L, Mann M, Gargioli C, Cesareni G.

Life Sci Alliance. 2019 Jun 25;2(3). pii: e201900437. doi: 10.26508/lsa.201900437. Print 2019 Jun.

4.

Osteogenic differentiation of skeletal muscle progenitor cells is activated by the DNA damage response.

Rosina M, Langone F, Giuliani G, Cerquone Perpetuini A, Reggio A, Calderone A, Fuoco C, Castagnoli L, Gargioli C, Cesareni G.

Sci Rep. 2019 Apr 1;9(1):5447. doi: 10.1038/s41598-019-41926-3.

5.

Phosphoproteomics Reveals the GSK3-PDX1 Axis as a Key Pathogenic Signaling Node in Diabetic Islets.

Sacco F, Seelig A, Humphrey SJ, Krahmer N, Volta F, Reggio A, Marchetti P, Gerdes J, Mann M.

Cell Metab. 2019 Jun 4;29(6):1422-1432.e3. doi: 10.1016/j.cmet.2019.02.012. Epub 2019 Mar 14.

PMID:
30879985
6.

The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling.

Reggio A, Spada F, Rosina M, Massacci G, Zuccotti A, Fuoco C, Gargioli C, Castagnoli L, Cesareni G.

Sci Rep. 2019 Mar 13;9(1):4360. doi: 10.1038/s41598-019-39538-y.

7.

Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.

La Regina G, Bai R, Rensen WM, Di Cesare E, Coluccia A, Piscitelli F, Famiglini V, Reggio A, Nalli M, Pelliccia S, Da Pozzo E, Costa B, Granata I, Porta A, Maresca B, Soriani A, Iannitto ML, Santoni A, Li J, Miranda Cona M, Chen F, Ni Y, Brancale A, Dondio G, Vultaggio S, Varasi M, Mercurio C, Martini C, Hamel E, Lavia P, Novellino E, Silvestri R.

J Med Chem. 2013 Jan 10;56(1):123-49. doi: 10.1021/jm3013097. Epub 2012 Dec 27.

8.

Stroke in the young in Sicily: prevalence and clinical features.

Patti F, Failla G, Reggio A, Salemi G, Morgante L, Grigoletto F, Savettieri G, Di Perri R.

J Stroke Cerebrovasc Dis. 1998 May-Jun;7(3):196-9.

PMID:
17895081
9.

Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability.

Tedeschi G, Dinacci D, Lavorgna L, Prinster A, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Servillo G, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Paolillo A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone I, Salvatore M, Bonavita V, Alfano B.

J Neurol Sci. 2007 Dec 15;263(1-2):15-9. Epub 2007 Aug 1.

PMID:
17673234
10.

Effects of interferon beta-1a and -1b over time: 6-year results of an observational head-to-head study.

Patti F, Pappalardo A, Florio C, Politi G, Fiorilla T, Reggio E, Reggio A.

Acta Neurol Scand. 2006 Apr;113(4):241-7.

PMID:
16542163
11.

Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.

Nocentini U, Pasqualetti P, Bonavita S, Buccafusca M, De Caro MF, Farina D, Girlanda P, Le Pira F, Lugaresi A, Quattrone A, Reggio A, Salemi G, Savettieri G, Tedeschi G, Trojano M, Valentino P, Caltagirone C.

Mult Scler. 2006 Feb;12(1):77-87.

PMID:
16459723
12.

Possible increasing risk of multiple sclerosis in Catania, Sicily.

Nicoletti A, Patti F, Lo Fermo S, Sorbello V, Reggio E, Maimone D, Zappia M, Reggio A.

Neurology. 2005 Oct 25;65(8):1259-63.

PMID:
16247054
13.

Brain atrophy and lesion load in a large population of patients with multiple sclerosis.

Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.

Neurology. 2005 Jul 26;65(2):280-5.

PMID:
16043800
14.

Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey.

Nicoletti A, Bartoloni A, Sofia V, Bartalesi F, Chavez JR, Osinaga R, Paradisi F, Dumas JL, Tsang VC, Reggio A, Hall AJ.

Epilepsia. 2005 Jul;46(7):1127-32.

15.

Long-term survival of Parkinson's disease: a population-based study.

D'Amelio M, Ragonese P, Morgante L, Reggio A, Callari G, Salemi G, Savettieri G.

J Neurol. 2006 Jan;253(1):33-7. Epub 2005 Jul 18.

PMID:
16021349
16.

The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.

Reggio E, Nicoletti A, Fiorilla T, Politi G, Reggio A, Patti F.

J Neurol. 2005 Oct;252(10):1255-61. Epub 2005 Jun 6.

PMID:
15940386
17.

[Symptomatic management in multiple sclerosis].

Pappalardo A, Patti F, Restivo DA, Reggio A.

Clin Ter. 2004 Nov-Dec;155(11-12):505-28. Review. Italian.

PMID:
15861966
18.

A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily.

Nicoletti A, Lo Fermo S, Reggio E, Tarantello R, Liberto A, Le Pira F, Patti F, Reggio A.

J Neurol. 2005 Aug;252(8):921-5. Epub 2005 Mar 24.

PMID:
15789132
19.

Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.

Patti F, Reggio E, Palermo F, Fiorilla T, Politi G, Nicoletti A, Reggio A.

J Neurol. 2004 Dec;251(12):1502-6.

PMID:
15645351
20.

Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.

Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R, Farina D, Fazio MC, Girlanda P, Le Pira F, Liguori M, Lugaresi A, Nocentini U, Reggio A, Salemi G, Tedeschi G, Trojano M, Valentino P, Quattrone A.

J Neurol. 2004 Oct;251(10):1208-14.

PMID:
15503099
21.

Nontraumatic spinal cord injury: an Italian survey.

Citterio A, Franceschini M, Spizzichino L, Reggio A, Rossi B, Stampacchia G; Gruppo Italiano Studio Epidemiologico Mielolesioni.

Arch Phys Med Rehabil. 2004 Sep;85(9):1483-7.

PMID:
15375821
22.

[Spasticity in multiple sclerosis].

Pappalardo A, Patti F, Reggio A, Guglielmino A, Mangiameli S.

Clin Ter. 2004 Apr;155(4):135-8. Review. Italian.

PMID:
15354762
23.

[Management of neuropathic bladder in multiple sclerosis].

Pappalardo A, Patti F, Reggio A.

Clin Ter. 2004 May;155(5):183-6. Review. Italian.

PMID:
15344566
24.

Relationship between clinical variables and cognitive performances in migraineurs with and without aura.

Le Pira F, Lanaia F, ZappalĂ  G, Morana R, Panetta MR, Reggio E, Reggio A.

Funct Neurol. 2004 Apr-Jun;19(2):101-5.

PMID:
15274516
25.

[Neuroprotective effects of topiramate].

Pappalardo A, Liberto A, Patti F, Reggio A.

Clin Ter. 2004 Feb-Mar;155(2-3):75-8. Review. Italian.

PMID:
15244111
26.

Epilepsy and multiple sclerosis in Sicily: a population-based study.

Nicoletti A, Sofia V, Biondi R, Lo Fermo S, Reggio E, Patti F, Reggio A.

Epilepsia. 2003 Nov;44(11):1445-8.

27.

A screening instrument for a Sicilian neuroepidemiological survey in the elderly.

Nicoletti A, Salemi G, Morgante L, Le Pira F, Epifanio A, Reggio A, Basile G, Savettieri G.

Arch Gerontol Geriatr. 2004 Jan-Feb;38(1):37-44.

PMID:
14599702
28.

An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients.

Grimaldi LM, Pincherle A, Martinelli-Boneschi F, Filippi M, Patti F, Reggio A, Franciotta D, Allegra L, Comi G, Blasi F.

Mult Scler. 2003 Oct;9(5):467-71.

PMID:
14582771
29.

Apolipoprotein E genotype does not influence the progression of multiple sclerosis.

Savettieri G, Andreoli V, Bonavita S, Cittadella R, Caltagirone C, Fazio MC, Girlanda P, Le Pira F, Liguori M, Logroscino G, Lugaresi A, Nocentini U, Reggio A, Salemi G, Serra P, Tedeschi G, Toma L, Trojano M, Valentino P, Quattrone A.

J Neurol. 2003 Sep;250(9):1094-8.

PMID:
14504972
30.

Prevalence of Parkinson's disease: a door-to-door survey in rural Bolivia.

Nicoletti A, Sofia V, Bartoloni A, Bartalesi F, Gamboa Barahon H, Giuffrida S, Reggio A.

Parkinsonism Relat Disord. 2003 Oct;10(1):19-21.

PMID:
14499202
31.

Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients--a randomised controlled trial.

Patti F, Ciancio MR, Cacopardo M, Reggio E, Fiorilla T, Palermo F, Reggio A, Thompson AJ.

J Neurol. 2003 Jul;250(7):861-6.

PMID:
12883930
32.

Health-related quality of life and depression in an Italian sample of multiple sclerosis patients.

Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, Reggio A.

J Neurol Sci. 2003 Jul 15;211(1-2):55-62.

PMID:
12767498
33.

[Neurogenic dysphagia: physiology, physiopathology and rehabilitative treatment].

Patti F, Emmi N, Restivo DA, Liberto A, Pappalardo A, Torre LM, Reggio A.

Clin Ter. 2002 Nov-Dec;153(6):403-19. Review. Italian.

PMID:
12645398
34.

Interferon beta and multiple sclerosis: look at the evidence.

Patti F, Reggio A.

Int J Clin Pract Suppl. 2002 Sep;(131):23-32.

PMID:
12564809
35.

The impact of outpatient rehabilitation on quality of life in multiple sclerosis.

Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M, Reggio A.

J Neurol. 2002 Aug;249(8):1027-33.

PMID:
12195449
36.

The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy.

Amato MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, Pitaro M, Reggio A, Trojano M; Mu. S. I. C. Study Group.

J Neurol. 2002 Feb;249(2):152-63.

PMID:
11985380
37.

Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia.

Nicoletti A, Bartoloni A, Reggio A, Bartalesi F, Roselli M, Sofia V, Rosado Chavez J, Gamboa Barahona H, Paradisi F, Cancrini G, Tsang VC, Hall AJ.

Neurology. 2002 Apr 23;58(8):1256-61.

PMID:
11971095
38.

Lifetime prevalence of Bell's palsy in rural Bolivia: a door-to-door survey.

Nicoletti A, Sofia V, Bartoloni A, Bartalesi F, Marletta C, Lo Bartolo ML, Rosado J, Le Pira F, Reggio A.

Neuroepidemiology. 2002 Mar-Apr;21(2):100-4.

PMID:
11901280
39.

Impact of sociodemographic characteristics on cognitive performance in an elderly Sicilian population.

Salemi G, Reggio A, Morgante L, Grigoletto F, Patti F, Meneghini F, Aridon P, Di Perri R, Savettieri G.

Neuroepidemiology. 2002 Jan-Feb;21(1):44-9.

PMID:
11744825
40.

Door-to-door prevalence survey of epilepsy in three Sicilian municipalities.

Rocca WA, Savettieri G, Anderson DW, Meneghini F, Grigoletto F, Morgante L, Reggio A, Salemi G, Patti F, Di Perri R; Sicilian Neuro-Epidemiologic Study (SNES) Group.

Neuroepidemiology. 2001 Oct;20(4):237-41.

PMID:
11684899
41.

Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis.

Patti F, Cataldi ML, Nicoletti F, Reggio E, Nicoletti A, Reggio A.

J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):404-7.

42.

Increased serum levels of interleukin-18 in patients with multiple sclerosis.

Nicoletti F, Di Marco R, Mangano K, Patti F, Reggio E, Nicoletti A, Bendtzen K, Reggio A.

Neurology. 2001 Jul 24;57(2):342-4.

PMID:
11468327
43.

Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat.

Di Marco R, Puglisi G, Papaccio G, Nicoletti A, Patti F, Reggio A, Bendtzen K, Nicoletti F.

Mult Scler. 2001 Apr;7(2):101-4.

PMID:
11424629
45.

Prevalence of stroke : a door-to-door survey in rural Bolivia.

Nicoletti A, Sofia V, Giuffrida S, Bartoloni A, Bartalesi F, Bartolo ML, Fermo SL, Cocuzza V, Gamboa H, Salazar E, Reggio A.

Stroke. 2000 Apr;31(4):882-5.

PMID:
10753992
46.

Prevalence and incidence of multiple sclerosis in Catania, Sicily.

Nicoletti A, Lo Bartolo ML, Lo Fermo S, Cocuzza V, Panetta MR, Marletta C, Ciancio MR, Cataldi ML, Patti F, Reggio A.

Neurology. 2001 Jan 9;56(1):62-6.

PMID:
11148237
47.

Deafness: an unusual onset of genetic Creutzfeldt-Jakob disease.

Cataldi ML, Restivo O, Reggio E, Restivo DA, Reggio A.

Neurol Sci. 2000 Feb;21(1):53-5. Erratum in: Neurol Sci 2000 Jun;21(3):172.

PMID:
10938203
48.

Stroke incidence and survival in three Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group.

Rocca WA, Reggio A, Savettieri G, Salemi G, Patti F, Meneghini F, Grigoletto F, Morgante L, Di Perri R.

Ital J Neurol Sci. 1998 Dec;19(6):351-6.

PMID:
10935829
49.

Isolated, unilateral, reversible palsy of the hypoglossal nerve.

Giuffrida S, Lo Bartolo ML, Nicoletti A, Reggio E, Lo Fermo S, Restivo DA, Domina E, Reggio A.

Eur J Neurol. 2000 May;7(3):347-9. Review.

PMID:
10886321
50.

Is season of birth associated with multiple sclerosis?

Salemi G, Ragonese P, Aridon P, Reggio A, Nicoletti A, Buffa D, Conte S, Savettieri G.

Acta Neurol Scand. 2000 Jun;101(6):381-3.

PMID:
10877153

Supplemental Content

Loading ...
Support Center